EUVIMEDEUVIMED entdecken
Crossref

Imaging of bacterial infection: Harnessing positron emission tomography and Cherenkov luminescence imaging with UBI‐derived octapeptide

Jyotsna Bhatt Mitra, Archana Mukherjee iD, Anuj Kumar, Ashok Chandak, Sutapa Rakshit, Hansa D Yadav, Badri Narain Pandey, Haladhar Dev Sarma

Drug Development Research · 2023

DOI: 10.1002/ddr.22103 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Development Research, 2023. Verfasst von Jyotsna Bhatt Mitra und 7 weiteren Autor:innen. Beteiligte Einrichtung: Radiopharmaceuticals Division, Bhabha Atomic Research Centre (BARC), Mumbai, India. Hauptthemen laut MEDLINE: Gallium Radioisotopes, Staphylococcal Infections. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: Department of Atomic Energy, Government of India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Noninvasive imaging techniques for the early detection of infections are in high demand. In this study, we present the development of an infection imaging agent consisting of the antimicrobial peptide fragment UBI (31–38) conjugated to the chelator 1,4,7‐triazacyclononane,1‐glutaric acid‐4,7‐acetic acid (NODAGA), which allows for labeling with the positron emitter Ga‐68. The preclinical evaluation of [ 68 Ga]Ga–NODAGA–UBI (31–38) was conducted to investigate its potential for imaging bacterial infections caused by Staphylococcus aureus . The octapeptide derived from ubiquicidin, UBI (31–38), was synthesized and conjugated with the chelator NODAGA. The conjugate was then radiolabeled with Ga‐68. The radiolabeling process and the stability of the radio formulation were confirmed through chromatography. The study included both in vitro evaluations using S. aureus and in vivo evaluations in an animal model of infection and inflammation. Positron emission tomography (PET) and Cherenkov luminescence imaging (CLI) were performed to visualize the targeted localization of the radio formulation at the site of infection. Ex vivo biodistribution studies were carried out to quantify the uptake of the radio formulation in different organs and tissues. Additionally, the uptake of [ 18 F]Fluorodeoxyglucose ([ 18 F] FDG) in the animal model was also studied for comparison. The [ 68 Ga]Ga–NODAGA–UBI (31–38) complex consistently exhibited high radiochemical purity (>90%) after formulation. The complex demonstrated stability in saline, phosphate‐buffered saline, and human serum for up to 3 h. Notably, the complex displayed significantly higher uptake in S. aureus , which was inhibited in the presence of unconjugated UBI (29–41) peptide, confirming the specificity of the formulation for bacterial membranes. Bacterial imaging capability was also observed in PET and CLI images. Biodistribution results indicated a substantial target‐to‐nontarget ratio of approximately 4 at 1 h postinjection of the radio formulation. Conversely, the uptake of [ 18 F]FDG in the animal model did not allow for the discrimination of infected and inflamed sites. Our studies have demonstrated that [ 68 Ga]Ga–NODAGA–UBI (31–38) holds promise as a radiotracer for imaging bacterial infections caused by S. aureus .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gallium RadioisotopesStaphylococcal InfectionsAnimalsHumansFluorodeoxyglucose F18Staphylococcus aureusTissue DistributionLuminescencePositron-Emission TomographyChelating AgentsAcetatesHeterocyclic Compounds, 1-Ring

Stichwörter der Autor:innen

68Ga labeled UBI (29-41)Cherenkov luminescence imaging[68Ga]Ga-NODAGA-UBI (31-38)infection imagingpositron emission tomographyradiolabeled ubiquicidin fragments

Substanzen

Gallium RadioisotopesFluorodeoxyglucose F18Chelating Agents1-(1,3-carboxypropyl)-4,7-carboxymethyl-1,4,7-triazacyclononaneAcetatesHeterocyclic Compounds, 1-RingGallium-68

Autor:innen und Institutionen

  • Radiopharmaceuticals Division, Bhabha Atomic Research Centre (BARC), Mumbai, India.
  • Homi Bhabha National Institute, Mumbai, India.
  • Board of Radiation & Isotope Technology, Navi Mumbai, India.
  • Radiation Medicine Centre, Bhabha Atomic Research Centre (BARC), Mumbai, India.
  • Radiation Biology & Health Sciences Division, Bhabha Atomic Research Centre (BARC), Mumbai, India.

ORCID-Profile: Archana Mukherjee

Förderung

  • Department of Atomic Energy, Government of India

Zitieren

APA

Mitra, J. B., Mukherjee, A., Kumar, A., Chandak, A., Rakshit, S., Yadav, H. D., Pandey, B. N., & Sarma, H. D. (2023). Imaging of bacterial infection: Harnessing positron emission tomography and Cherenkov luminescence imaging with UBI‐derived octapeptide. Drug Development Research. https://doi.org/10.1002/ddr.22103

Vancouver

Mitra JB, Mukherjee A, Kumar A, Chandak A, Rakshit S, Yadav HD, et al. Imaging of bacterial infection: Harnessing positron emission tomography and Cherenkov luminescence imaging with UBI‐derived octapeptide. Drug Development Research. 2023. doi:10.1002/ddr.22103

BibTeX
@article{Mitra2023,
  author = {Mitra, Jyotsna Bhatt and Mukherjee, Archana and Kumar, Anuj and Chandak, Ashok and Rakshit, Sutapa and Yadav, Hansa D and Pandey, Badri Narain and Sarma, Haladhar Dev},
  title = {Imaging of bacterial infection: Harnessing positron emission tomography and Cherenkov luminescence imaging with UBI‐derived octapeptide},
  journal = {Drug Development Research},
  year = {2023},
  doi = {10.1002/ddr.22103}
}
Kostenlos starten →